FindTrial
Sign In

The application of new technology in the auxiliary diagnosis, curative effect evaluation, prognosis judgment and recurrence monitoring of Pan cancer

The application of new technology in the auxiliary diagnosis, curative effect evaluation, prognosis judgment and recurrence monitoring of Pan cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127181
Enrollment
Unknown
Registered
2026-06-26
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Benign and malignant pulmonary nodules:None

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed by histopathology; 2. Having pathological sections available for analysis; 3. Have complete and traceable basic clinical information and treatment follow-up data (including diagnosis, treatment, efficacy evaluation and survival outcome).

Exclusion criteria

Exclusion criteria: 1. Incomplete key clinical or follow-up data; 2. Specimen quality is unqualified; 3. Patients with other active malignancies at the same time.

Design outcomes

Primary

MeasureTime frame
EGFR Gene Mutation;—

Countries

China

Contacts

Public ContactXu Yinhai

The Affiliated Hospital of Xuzhou Medical University

1755789156@qq.com+86 516 85802359

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026